期刊文献+

序贯疗法和三联疗法治疗幽门螺杆菌阳性溃疡的疗效观察 被引量:15

Eradication of Helicobacter pylori with ten days sequential therapy and standard triple therapies
下载PDF
导出
摘要 目的观察由奥美拉唑联合阿莫西林、克拉霉素、替硝唑组成的10日序贯疗法根除幽门螺杆菌(Hp)的疗效。方法210例Hp阳性的消化性溃疡患者,随机分为两组。治疗组采用前5 d应用奥美拉唑20 mg加阿莫西林1000 mg,2次/d,后5 d用奥美拉唑20 mg加克拉霉素500 mg加替硝唑500 mg,2次/d,对照组采用10 d奥美拉唑20 mg加阿莫西林1 000 mg加克拉霉素500 mg,2次/d。4周后复查Hp。结果治疗组Hp根除率92.4%,对照组78.1%,差异有统计学意义(P<0.05)。结论以奥美拉唑、阿莫西林、克拉霉素、替硝唑组成的10日序贯疗法治疗成人Hp感染具有疗效高、耐受性和依从性好等优点。 Objective To evaluate the eradication of ten days sequential therapy consisted of omeperazole, clarithromycin, amoxicillin and tinidazole on Helicobacter pylori(Hp) infection. Methods 210 patients with Hp positive were randomly divided into two groups. 110 patients were treated with omcperazole,amoxicillin at first five days,omeperazole,clarithromycin and tinidazole at the second five days. The control group( 110 patients) were treated with omeperazole, elarithromycin and amoxicillin for ten days. Results The eradication rate of ten days sequential therapy was 92.4% and that of control group was 78.1%. The differences between two groups were significant( P 〈 0.05 ). Conclusion Ten days sequential therapy is more effective, wen tolerated and with higher rate of eradication.
作者 刘健
出处 《临床和实验医学杂志》 2009年第4期72-73,共2页 Journal of Clinical and Experimental Medicine
关键词 序贯疗法 三联疗法 幽门螺杆菌 根除率 Sequential therapy Standard triple therapy Helicobacter pylori Eradication
  • 相关文献

参考文献6

二级参考文献31

  • 1Malfertheiner P, Mégraud F, O Morain C, et al. Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther,2002,16:167-180. 被引量:1
  • 2Mégraud F, Hazell S, Glupczynski Y. Antibiotic susceptibility and resistance. In: Mobley HLT, Mendz GL, Hazell SL, eds.Helicobacter pylori: Physiology and Genetics. Washington DC:ASM Press,2001. 511-530. 被引量:1
  • 3Mégraud F. Helicobacter pylori and macrolides. In: Schonfeld W, Kirst HA, eds. Macrolide antibiotics. Berlin: Birkhauser,2002. 243-260. 被引量:1
  • 4Gisbert JP, Calvet X, Bujanda L, et al. Rescue' therapy with rifabutin after multiple Helicobacter pylori treatment failures.Helicobacter, 2003,8: 90-94. 被引量:1
  • 5Masconi G, Parente F, Russo A, et al. Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy? Am J Gastroenterol, 2001,96: 359-366. 被引量:1
  • 6Baena JM, Lopez C, Hidalgo A, et al. Relation between alcohol consumption and the success of Helicobacter pylori eradication therapy using omeprazole, clarithromycin and amoxicillin for 1 week. Eur J Gastroenterol Hepatol, 2002,14: 291-296. 被引量:1
  • 7Amieva MR, Salama NR, Tompkins LS, et al. Helicobacter pylori enter and survive within multivesicular vacuoles of epithelial cells. Cell Microbiol, 2002,4 : 677-690. 被引量:1
  • 8Matysiak-Budnik T, Heyman M, Candalh C, et al. In vitro transfer of clarithromycin and amoxicillin across the epithelial barrier. J Antimicrob Chemother, 2002,50: 865-872. 被引量:1
  • 9Rabelo-Goncalves EM, Nishimura NF, Zeitune JM. Acute inflammatory response in the stomach of BALB/c mice chal lenged with coccoidal Helicobacter pylori. Mem Inst Oswaldo Cruz,2002,97:1201-1206. 被引量:1
  • 10Broutet N, Tchamgoué S, Pereira E, et al. Risk factors for failure of Helicobacter pylori therapy. Results of an individual data analysis of 2751 patients. Aliment Pharmacol Ther, 2003,17:99-109. 被引量:1

共引文献741

同被引文献87

引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部